Merck invests $50m in Personalis to bolster Moderna collaboration on individualized cancer therapies
Personalis, Inc., a leader in precision oncology solutions, has secured a significant investment from Merck and extended its partnership with Moderna. These strategic agreements aim ... Read More
Is US facing new COVID-19 nightmare? KP.2 variant pushes hospitalization rates to record levels
The United States is grappling with the most severe COVID-19 surge since 2022, characterised by a sharp increase in hospitalisation rates and intensified viral activity. ... Read More
Moderna, Merck announce promising results for mRNA-4157 and Keytruda in melanoma
Moderna, Inc. (NASDAQ: MRNA) and Merck (NYSE: MRK), also known as MSD outside the United States and Canada, today revealed follow-up data from their collaborative ... Read More
Moderna, Merck get FDA breakthrough status for mRNA-4157/V940, KEYTRUDA combo in melanoma
Moderna and Merck announced that the investigational personalized mRNA cancer vaccine mRNA-4157/V940 in combination with the latter’s lung cancer drug KEYTRUDA (pembrolizumab) has been given ... Read More
Moderna to acquire Japanese biotech firm OriCiro Genomics for $85m
Moderna has agreed to acquire OriCiro Genomics, a Japanese biotech firm involved in developing cell-free synthesis and amplification of plasmid DNAs for applications in gene ... Read More
Moderna, Thermo Fisher sign manufacturing agreement for Spikevax vaccine
Moderna has entered into a 15-year collaboration agreement with Thermo Fisher Scientific to enable dedicated large-scale US manufacturing of Spikevax, the former’s Covid-19 vaccine as ... Read More
Moderna to build mRNA vaccine manufacturing plant in Victoria
Moderna has signed an agreement in principle with the Government of Australia to build a messenger RNA (mRNA) vaccine manufacturing plant in Victoria. According to ... Read More
US biotech company Moderna to build $500m mRNA facility in Africa
Moderna will invest up to $500 million to construct a messenger RNA facility (mRNA facility) in Africa with an aim to produce up to 500 ... Read More
Indian government approves use of Moderna’s Covid-19 Vaccine Moderna
US biotech company Moderna has been given emergency use authorization from the Indian government for its Covid-19 Vaccine Moderna (mRNA-1273) in adults aged 18 years ... Read More
Samsung Biologics to manufacture Moderna’s mRNA-1273 COVID-19 vaccine
Moderna has signed a manufacturing services and supply agreement with Samsung Biologics under which the latter will undertake large scale, commercial fill-finish manufacturing for the ... Read More